Investor Relations

Living Cell Technologies is a fast growing public bioscience company listed on the both the Australian Stock Exchange and the International OTCQX.

With over 1200 shareholders from Australasia, Europe and the United States of America, LCT is focused on building an global cellular theraputics business that will have its own capabilities of providing live cell therapies in Asia Pacific, USA and Europe through the commercialisation of products currently being tested.